All Posts

Pharmagene Discovery Services are proud to be the first Certified Service Provider for the Jess™ Simple Western™ platform in the UK. Jess is an advanced automated platform from Bio-Techne that delivers accurate, reproducible and quantitative protein expression data/analysis. Our scientific team has completed a dedicated training programme led by Bio-Techne’s expert field application scientists, equipping them with the knowledge and practical expertise to ensure optimal use of

Tissue Cross-Reactivity (TCR) studies are an important component in the safety evaluation of biotherapeutics and antibody-like molecules. They are designed to identify potential off-target binding to human tissues to mitigate risk following systemic exposure, in particular to pharmacologically active antibodies or cytotoxic immunoconjugates.

Meet the leadership team at Pharmagene Discovery Services as they discuss human tissue–based research, scientific innovation, and the future of translational discovery.

This announcement marks the official launch of Pharmagene Discovery Services Ltd. Originally founded in 1996, the Royston team has been at the forefront of human tissue-based research for three decades. Now, under its original name and leadership from a co-founding management team with deep roots in the business, Pharmagene Discovery Services begins its next chapter as an independent specialist partner to the global biopharma community.